CDMO: Complex Small Molecules
Oncology, Immunology
Preclinical to Phase IIIDevelopment & Manufacturing
Key Facts
Indication
Oncology, Immunology
Phase
Preclinical to Phase III
Status
Development & Manufacturing
Company
About EuroAPI
EuroAPI's mission is to ensure a reliable, high-quality supply of essential active pharmaceutical ingredients (APIs) to secure global healthcare sovereignty. Since its 2022 spin-off and public listing, it has established itself as a critical, independent supplier with a vast portfolio and a resilient European manufacturing footprint. Its strategy is built on four pillars: quality and compliance, customer centricity, operational excellence, and sustainability, positioning it as a key enabler for both established generics and novel drug development.
View full company profileTherapeutic Areas
Other Oncology, Immunology Drugs
| Drug | Company | Phase |
|---|---|---|
| Biosimilars Portfolio | Lupin | Various |
| Internal Antibody Discovery Programs | Biocytogen | Pre-clinical |
| Biosimilar Development Programs | Torrent Pharmaceuticals | Development/Clinical Trials |
| Biosimilars Pipeline | Alkem Laboratories | Development / Clinical Trials |
| Generic Biologics Pipeline | Gland Pharma | Development |